Clinical Trials Browser

Interventional × Advance Solid Tumors × 90 days × Clear all

NCT07529535 2026-04-17

A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors

Phase 1 Suspended

Other solid neoplasm

Advance Solid Tumors